About: Kenneth A. Freedberg

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Kenneth A. Freedberg Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) araştırmacı (tr) дослідник (uk) изилдөөчү (ky) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Kenneth A Freedberg (nl) Kenneth A. Freedberg (en)
skos:prefLabel	Kenneth A Freedberg (nl) Kenneth A. Freedberg (en)
name	Kenneth A Freedberg (nl) Kenneth A. Freedberg (en)
given name	wds:Q87347438-215AEC3E-58C7-439E-8F6A-537A04C90098
given name	Kenneth
instance of	wds:Q87347438-33D028D3-3D56-432F-9008-34796C6654EB
instance of	Homo sapiens
skos:altLabel	Freedberg (en) Freedberg K. (en) Freedberg K. A. (en) Freedberg KA (en) K A Freedberg (en) K Freedberg (en) K. A. Freedberg (en) K. Freedberg (en) K.A. Freedberg (en) Kenneth A Freedberg (en) Kenneth Freedberg (en)
occupation	wds:Q87347438-B2C734EB-11E3-4D02-AE59-78C3F2FD943C
sex or gender	wds:Q87347438-e7f000ac-49d3-59ad-4e37-5c60f75be234
father	wds:Q87347438-2a66c07d-491f-1a81-03b7-c596ff7e8745
spouse	wds:Q87347438-fa7b8786-4bb0-1a41-35c3-5de2289db259
occupation	researcher
sex or gender	male
father	Irwin Freedberg
spouse	Joyce Susan Jen
ORCID iD	wds:Q87347438-59F51BE6-6FFC-408B-8BAA-82563DA3C036 wds:Q87347438-66694E6F-4D76-4397-94E9-3D269187C889
ORCID iD	https://orcid.org/0000-0001-6471-7930 https://orcid.org/0000-0003-3143-7822
ORCID iD	0000-0001-6471-7930 0000-0003-3143-7822
is owl:sameAs of	Kenneth A. Freedberg Kenneth A. Freedberg
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87347438
is author of	Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients Provider-initiated HIV testing in rural Haiti: low rate of missed opportunities for diagnosis of HIV in a primary care clinic Improving outcomes in state AIDS drug assistance programs Optimizing resource allocation in United States AIDS drug assistance programs. Think HIV: why physicians should lower their threshold for HIV testing. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines The cost-effectiveness of preventing AIDS-related opportunistic infections The survival benefits of AIDS treatment in the United States Assessing the impact of federal HIV prevention spending on HIV testing and awareness Scaling up antiretroviral therapy in South Africa: the impact of speed on survival State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards. The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa The cost effectiveness of combination antiretroviral therapy for HIV disease. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions HIV/AIDS, undernutrition, and food insecurity The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa Loss to care and death before antiretroviral therapy in Durban, South Africa Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Improving Participation in HIV Clinical Trials: Impact of a Brief Intervention Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India Diagnostic point-of-care tests in resource-limited settings The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach Cost-effectiveness of genotype testing for primary resistance in Brazil The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men Cost-effectiveness of HIV treatment as prevention in serodiscordant couples Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection Implementing a routine, voluntary HIV testing program in a Massachusetts county prison Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005. Antischizophrenic drugs: Differential plasma protein binding and therapeutic activity HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire Trillion virion delay: time from testing positive for HIV to presentation for primary care. Factors associated with initiation of primary medical care for HIV-infected persons The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software